INCLINE VILLAGE, Nev., April 18, 2011 /PRNewswire/ —
PDL BioPharma, Inc. (PDL) (NASDAQ:
PDLI) today announced that the company will hold its annual
meeting of stockholders on Wednesday, June 22, 2011 at 10:00 a.m.
Pacific Time for all stockholders of record on April 25, 2011. The
meeting will take place at the Hyatt Regency Hotel in Incline
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by
doing so, enabled the discovery of a new generation of targeted
treatments for cancer and immunologic diseases. PDL is focused on
maximizing the value of its antibody humanization patents and
related assets. The Company receives royalties on sales of a number
of humanized antibody products marketed by leading pharmaceutical
and biotechnology companies today based on patents which expire in
late 2014. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered
trademarks of PDL BioPharma, Inc.